Orthobiologics Market Is Forecast To Reach $10.2 Billion By 2025

San Francisco, 29 October 2018 - According to a report published by Grand View Research, Inc.; the orthobiologics market is expected to reach a valuation of around USD 10.2 billion by 2024.
Rise in prevalence of orthopedic disease and musculoskeletal disease across the world, growing number of orthopedic procedures due to accidence and obesity can propel the market during the forecast period (2014 to 2025). In addition, increasing geriatric population which are at high risk to spinal and other orthopedic disorders are also leading orthopedic surgeries.

Orthobiologics market, by product, 2014 - 2025 (USD Billion)
orthobiologics-market
Technological developments in biomaterials used in the manufacturing of orthobiologics are expected to accelerate the market growth in the coming years. These developments include modifications in graft designs, development of recombinant biologic agents, cultured tissue scaffolds, and stem cell therapy. These advancements can offer many benefits such as improved biocompatibility, smaller incisions, and reduction in surgical time. Moreover, these innovative solutions are assumed to efficiently decrease the repetition of post-operative complications. This is likely to spur the market growth in the coming years.

Worldwide orthobiologics market can be segmented on the basis of product, application, end-use, and region.

As per product, the market can be segmented on the basis of demineralized bone matrix (DBM), allograft, bone morphogenetic protein (BMP), viscosupplementation, synthetic bone substitutes, and stem cell therapy.

The viscosupplementation segment held for the major share in 2015. This can be credited to high utilization of these products because of its availability and impressive use in complaints including hip degenerative joint disease and osteoarthritis. It offers several benefits such as pain reduction, less side-effects, minimum incision, better knee movement. Increasing popularity of minimally invasive surgeries are also expected to boost the segment in the coming years.

As per application, the market can be split into spinal fusion, trauma repair, and reconstructive surgery.

Browse Research Report On Orthobiologics Market :
www.grandviewresearch.com/industry-analysis/orthobiological-products-market
The spinal fusion segment estimated for the largest share over 50.0% in 2015. This can be attributed to high utilization of bone morphogenetic proteins, demineralized bone matrices, autografts and allografts in spinal fusion procedures due to its capability to provide better stability to bone and fast bone healing. This leads to improvement of long-term spinal disorders. Other benefits include fast stimulation of cells to provide bone formation and avoids frequent hospital stay and visits.

On the basis of end-use, the market can be classified into hospitals and orthopedic clinics.
The hospitals segment estimated for the largest share in 2015. This can be attributed to growing use of orthobiological products in different spinal and reconstructive surgeries, which are performed in the hospitals. In addition, convenience of specialized patient care and easy availability of widespread range of products in hospitals is considered as the crucial driving factors for the segment.

Geographically, the market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

In 2015, North America estimated for the largest market share due to the presence of key players which are involved in encouraging quality care and are taking responsibility for new product development strategies. Additionally, availability of better reimbursement policies for soft tissue healing and fusion improvement products are also supporting the regional growth.

Asia Pacific is likely to expand swiftly over the forecast period due to increasing healthcare expenditure, rise in disposable income, growing physician awareness levels about the benefits of these products. Rapid development in healthcare infrastructure is also expected to provide lucrative gains across the region in the coming years. In addition, growing product launch across the region is also driving the growth in this region.

Some of the leading companies operating in the market include DePuy Synthes, Inc.; Medtronic; Stryker Corporation; Genzyme; and Smith & Nephew plc.

Major companies are involved in new product development activities, mergers and acquisitions, collaborations and distribution improvement strategies, and frequent product approval to gain traction in the market. Players are also making high investments for R&D. Increasing collaboration between biotechnology companies and medical device companies to develop advanced orthobiologics is expected to support the market growth.

View more reports of this category by Grand View Research athttps://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the orthobiologics market on the basis of product, application, end use, and region:

Orthobiologics Product Outlook (Revenue, USD Billion, 2014 - 2025)
  • Demineralized Bone Matrix(DBM)
  • Allograft
  • Bone Morphogenetic Protein (BMP)
  • Viscosupplementation
  • Synthetic Bone Substitutes
  • Stem Cell Therapy
Orthobiologics Application Outlook (Revenue, USD Billion, 2014 - 2025)
  • Spinal Fusion
  • Trauma Repair
  • Reconstructive Surgery
Orthobiologics End-use Outlook (Revenue, USD Billion, 2014 - 2025)
  • Hospitals
  • Orthopedic Clinics
Orthobiologics Regional Outlook (Revenue, USD Billion, 2014 - 2025)
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • Japan
    • China
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • South Africa

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Comments

Post a Comment

Popular posts from this blog

Matcha Market Is Anticipated to Attain Around $5.07 Billion By 2025

Image
San Francisco, 29 April 2019 – “ Matcha Market Analysis By Grade (Ceremonial, Classic, Culinary), By Application (Regular Tea, Matcha Beverages, Food, Personal Care), By Region, And Segment Forecasts, [2018 - 2025] ” The global matcha market is expected to reach USD 5.07 billion by 2025, according to a new report by Grand View Research, Inc. Rising prevalence of chronic diseases has augmented the demand for healthy and nutrient-rich food & beverage alternatives. Anti-oxidant and vitamin-rich composition of matcha tea has fueled the product demand across the globe. Anti-oxidants, including epigallocatechin gallate (EGCG), prevent diseases such as cancer, Type-2 diabetes, cardiovascular problems. EGCG present in the product can repair DNA damage caused by UV radiation and controls the proliferation of cancerous cells. The product also has the potential to reduce stress and promotes a state of relaxation. L-theanine present in the product acts in a synergistic way to activa...
Read more

Levulinic acid Market Strategy, Distributors & Manufacturing Cost Analysis Till 2020

Image
Global  levulinic acid market  demand was 2,606.2 tons in 2013 and is projected to be 3,820 tons by 2020. The increasing application of levulinic acid, especially in pesticides, solvents, pharmaceuticals, and cosmetics industries are anticipated to boost growth in the coming years. Over the past few years, the chemical industry has continually been striving towards attaining a sustainable growth, with a focus on the development of renewable biotechnological and bio-based products. The production technology for bio-based levulinic acid has been simplified by dehydration of biomass or carbohydrates with acid. Levulinic acid is being increasingly used as a substitute to its synthetic counterparts in industrial usage. Levulinic acid market volume share by application, 2013 The global levulinic acid market is anticipated to reach USD 19.65 million revenue, with a growing CAGR of 4.8% by 2020. Increasing usage of the acid in niche applications including plastics, nyl...
Read more

Endoscopy Devices Market Chances To Reach $17.19 Billion By 2025

Image
  The global  endoscopes market  size is expected to reach USD 17.19 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 8.8% during the forecast period. Growing global geriatric population, high prevalence of gastrointestinal diseases, and rising technological advancements are the key factors contributing to market growth. Rising preference for minimally invasive surgeries (MIS) is also positively influencing the growth of the market. Endoscopy surgeries are performed for diagnosis as well as treatment of gastrointestinal, gynecological, neurological, and cardiovascular diseases. Emergence of minimally invasive alternatives to open surgeries such as laparoscopy, hysteroscopy, and colonoscopy is boosting the demand for endoscopes. Preference of MIS is increasing owing to smaller incision, reduction in postoperative complications & mortality, and lesser trauma. Furthermore, they are economically viable alternatives to...
Read more